Infecção toxoplásmica causa hipertrofia da parede do cólon de frangos

Estudaram-se os efeitos da infecção toxoplásmica sobre a morfometria da parede intestinal, a distribuição de fibras colágenas e a dinâmica de mucinas secretadas no cólon de frangos. Foram utilizados 16 frangos machos de linhagem comercial, com 26 dias de idade. As aves foram distribuídas, aleatoriamente, em três grupos (G). As do G1 não receberam inóculo e se caracterizaram como grupo-controle; nas do G2, foram inoculados cistos teciduais da cepa ME49 de Toxoplasma gondii; e nos G3, oocistos da cepa M7741 de T. gondii. Após 60 dias da inoculação, os animais foram sacrificados para coleta do cólon, o qual foi submetido à rotina de processamento histológico. Em G2 e G3, observou-se hipertrofia da parede do cólon, contudo não houve alteração na proporção do número de células caliciformes e de enterócitos presentes no epitélio intestinal

Alterações do epitélio branquial e das lamelas de tilápias (Oreochromis niloticus) causadas por mudanças do ambiente aquático em tanques de cultivo intensivo The influence of the aquatic environment in tanks sequetially interconnected with PVC pipes on the gill epithelium and lamellas of tilapia (Oreochromis niloticus)

Objetivou-se analisar o comportamento do epitélio branquial de tilápias, cultivadas em tanques posicionados em diferentes altitudes e interconectados por tubos de PVC. Filamentos branquiais de quatro espécimes de quatro tanques (T1, T2, T3 e T4) interconectados seqüencialmente foram submetidos à rotina histológica, para obtenção de cortes de 5µm de espessura, os quais foram corados com Hematoxilina-Eosina, ou submetidos à técnica histoquímica para glicoconjugados: PAS + solução de diástase ou Alcian Blue pH 2,5 ou Alcian Blue pH 1,0. Considerando as regiões basal, intermediária e apical dos filamentos, mensurou-se a área lamelar e contou-se o número de células mucosas em cada uma dessas regiões, o que correspondia a 0,56 mm². Verificou-se que a concentração de oxigênio, pH e a temperatura se reduziam progressivamente com a passagem da água de um tanque para outro. Em função disso, constatou-se um aumento abrupto do número de células mucosas e da área lamelar no T2, e uma redução progressiva destas medidas nos tanques que recebiam água do T2. Além disso, observou-se nos animais do T2, T3 e T4, descolamento do epitélio branquial, hiperplasia celular no espaço interlamelar e telangectasias. Conclui-se que o ambiente aquático de tanques interconectados seqüencialmente por tubos de PVC se altera ao passar de um tanque para o outro, e que estas flutuações físico-químicas se refletem no comportamento do epitélio branquial através de variações da área lamelar e do número de células mucosas.<br>The behavior of the gill epithelium of tilapias cultured in tanks at different altitudes and interconnected with PVC pipes was analyzed. Gill filaments of four specimens from four tanks (T1, T2, T3 e T4) sequentially interconnected were submitted to histological routine to obtain 5-mm-thick cuts that were stained with HE or submitted to histochemistry reactions PAS + diastase solution or Alcian Blue pH 2.5 or Alcian Blue pH 1.0. Considering the intermediary, apical and basal regions of the filaments, the lamellar area was measured and the amount of mucous cells was counted. It was verified that oxygen, pH, and temperature decreased progressively as the water flew from one tank to another. Thus, an increase was realized of the amount of mucous cells and the lamellar area in T2, as well as a progressive decrease of these measures on the tanks which received water from T2. Moreover, detachment of the gill epithelium, cellular hyperplasia in the interlamellar space, and telangectasias were observed in the fishes from T2, T3 e T4. It was concluded that the aquatic environment in tanks sequentially interconnected with PVC pipes suffers alterations from one tank to another, as that physico-chemical fluctuations reflect on the behavior of the gill epithelium through variations of the lamellar area and the amount of mucous cells

Epiderme dos segmentos foliares de Mauritia flexuosa L. f. (Arecaceae) em três fases de desenvolvimento Epidermis of leaf segments from Mauritia flexuosaL. f. (Arecaceae) on three phases of development

São apresentados os dados anatômicos da epiderme dos segmentos foliares de Mauritia flexuosa L. f. (Arecaceae) em três fases do desenvolvimento. Os segmentos foliares foram analisados em toda a extensão do limbo. As células intercostais da epiderme das faces adaxial e abaxial evidenciam-se com paredes sinuosas, retangulares e orientadas longitudinalmente em relação ao eixo do segmento foliar com acentuada presença de corpos de sílica esférico-espinulosos. As células epidérmicas da região costal de ambas as faces apresentam paredes retas e variam entre curtas, longas e arredondadas. Os tricomas são simples, unicelulares, longos, com base mais alargada. Os segmentos foliares de M. flexuosa são anfiestomáticos com estômatos tetracíticos. Em secção transversal a epiderme foliar é uniestratificada com câmara subestomática ampla. Os resultados obtidos não demonstraram variações expressivas entre as três fases de desenvolvimento e os caracteres encontrados parecem ser comuns a outras palmeiras.<br>Anatomic data on the epidermis leaf segments from Mauritia flexuosa L. f. (Arecaceae) are presented on three phases of development. Leaf segments were analyzed on the all extension of leaf. Both adaxial and abaxial epidermal cells stand out with sinuous walls, rectangular and longitudinally oriented to the foliar axis with the marked presence of spherical- spiny silica bodies. The back epidermal cells of both surfaces present straight walls and vary among short, long and round. Trichomes are unicellular, simple, long, with a wider base. Leaf segments from M. flexuosa are anphistomatic with tetracitic type stomats. In a cross-section the leaf skin is unistratified with a broad substimatic chamber. The findings obtained showed no significant variations among the three phases of development and the characters that were found appear to be common on other palm trees

Investigando a hipótese da paridade do poder de compra: um enfoque não linear Testing the long-run purchasing power parity hypothesis: a nonlinear approach

A hipótese da Paridade do Poder de Compra (PPP) é investigada analisando-se a dinâmica de longo prazo da taxa de câmbio real efetiva no Brasil. Com dados mensais, o objetivo principal do estudo é testar a hipótese da PPP com um enfoque não linear. A metodologia empregada baseou-se na aplicação de testes gerais (Keenan, 1985; Tsay, 1986) e específicos para não linearidade do tipo Threshold (Chan, 1990). Seguindo-se a metodologia de Hansen (1999), o estágio seguinte consistiu em testar o número de regimes necessários para descrever a dinâmica não linear da taxa de câmbio real. Os resultados das estimações sugerem a ocorrência de apenas dois regimes distintos, com persistência e volatilidade diferentes. Conclui-se que a hipótese da PPP é apoiada pelos resultados.<br>We consider a threshold time series model in order to test the PPP hypothesis with Brazilian effective real exchange rate dataset in the long run. By following Keenan (1985), Tsay (1986) and Chan (1990), we test Brazilian dataset for several types of nonlinearities. So, after apply Hansen's test to infer about the number of regimes, we apply the more recent methodology of Self-Exciting Threshold Autoregressive (SETAR) model to point out some threshold to which a signal of turning point could be given in the states of the exchange rate dynamics. All the tests suggest that the Brazilian real exchange rate is highly nonlinear. The skeleton of the SETAR models fitted shows that PPP hypothesis is supported in the long run in spite the deviations from short run

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0–100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0–100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8–98·1) in Iceland, followed by 96·6 (94·9–97·9) in Norway and 96·1 (94·5–97·3) in the Netherlands, to values as low as 18·6 (13·1–24·4) in the Central African Republic, 19·0 (14·3–23·7) in Somalia, and 23·4 (20·2–26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1–93·6) in Beijing to 48·0 (43·4–53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6–68·8) in Goa to 34·0 (30·3–38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle-SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view—and subsequent provision—of quality health care for all populations. Funding Bill & Melinda Gates Foundation

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8-98·1) in Iceland, followed by 96·6 (94·9-97·9) in Norway and 96·1 (94·5-97·3) in the Netherlands, to values as low as 18·6 (13·1-24·4) in the Central African Republic, 19·0 (14·3-23·7) in Somalia, and 23·4 (20·2-26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1-93·6) in Beijing to 48·0 (43·4-53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6-68·8) in Goa to 34·0 (30·3-38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view - and subsequent provision - of quality health care for all populations. Copyright © 2018 The Author(s). Published by Elsevier Ltd